ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,071.63
      0.02%
      US Tech 100
      16,867.60
      -0.80%
      Dow Jones
      38,460.92
      -0.11%
      Brent Oil
      87.345
      0.14%
      Bitcoin
      64,247.79
      -0.05%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Germany
      5. TG
      6. Seelos Therapeutics Inc (NXEN)

      7. Seelos Therapeutics Inc (NXEN) News

      NXEN

      Seelos Therapeutics (NXEN)

      		Date:
      Sort by:
       Showing the most relevant articles for your search:USOTC:NXEN
      DateTimeSourceHeadlineSymbolCompany
      02/20/20246:19AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:NXENNexien BioPharma Inc (QB)
      02/14/20246:04AMEdgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:NXENNexien BioPharma Inc (QB)
      11/02/20234:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:NXENNexien BioPharma Inc (QB)
      11/02/20234:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:NXENNexien BioPharma Inc (QB)
      09/28/20236:06AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:NXENNexien BioPharma Inc (QB)
      07/31/20235:41PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:NXENNexien BioPharma Inc (QB)
      07/31/20233:35PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:NXENNexien BioPharma Inc (QB)
      05/15/20233:35PMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:NXENNexien BioPharma Inc (QB)
      04/19/20236:49PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NXENNexien BioPharma Inc (QB)
      04/19/20234:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NXENNexien BioPharma Inc (QB)
      02/08/20236:18AMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:NXENNexien BioPharma Inc (QB)
      01/17/20231:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NXENNexien BioPharma Inc (QB)
      01/17/20231:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NXENNexien BioPharma Inc (QB)
      11/09/20226:22AMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:NXENNexien BioPharma Inc (QB)
      10/18/202212:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NXENNexien BioPharma Inc (QB)
      10/18/202211:05AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NXENNexien BioPharma Inc (QB)
      09/15/20224:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NXENNexien BioPharma Inc (QB)
      09/14/20225:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NXENNexien BioPharma Inc (QB)
      09/14/20225:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NXENNexien BioPharma Inc (QB)
      05/12/202212:36PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:NXENNexien BioPharma Inc (QB)
      02/08/20226:08AMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:NXENNexien BioPharma Inc (QB)
      01/31/20223:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NXENNexien BioPharma Inc (QB)
      01/21/20221:05PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:NXENNexien BioPharma Inc (QB)
      11/29/202112:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NXENNexien BioPharma Inc (QB)
      11/29/202112:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NXENNexien BioPharma Inc (QB)
      11/22/20219:57AMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:NXENNexien BioPharma Inc (QB)
      10/12/20216:16AMEdgar (US Regulatory)Annual Report (10-k)USOTC:NXENNexien BioPharma Inc (QB)
      09/28/20216:05AMEdgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:NXENNexien BioPharma Inc (QB)
      06/07/20216:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:NXENNexien BioPharma Inc (QB)
      02/11/20213:58PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:NXENNexien BioPharma Inc (QB)
       Showing the most relevant articles for your search:USOTC:NXEN